An observational study in Neuromuscular Disease, Chronic Respiratory Insufficiency and Intermittent Positive-pressure Ventilation, sponsored by Centre d'Investigation Clinique et Technologique 805. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-02-26.
Sponsored by Centre d'Investigation Clinique et Technologique 805 · Observational
The purpose of this study is to compare the measure of the CO2 obtained on the end-tidal expiratory gas (ETCO2) with the value of CO2 obtained by transcutaneous measure (PTCO2), in home-ventilated neuromuscular patients.
Monitoring of the effectiveness of ventilation in patients with neuromuscular require to regularly measure blood gases and in particular carbon dioxide (CO2). The reference technique is arterial puncture. In recent years, a non-invasive techniques measuring CO2 by transcutaneous sensor (PTCO2) was introduced among the tools regularly used for follow-up monitoring of home ventilated patients.
Another technique for monitoring CO2, originally developed for anesthesia, is based on the measurement of exhaled CO2 (ETCO2). This technique requires relatively simple equipment, and represents a potential alternative for monitoring home-ventilated patients.
Recently, sensors for ETCO2 were coupled to devices for home ventilation. To the best of our knowledge, the role of ETCO2 in monitoring long-term ventilated patients has not been investigated to date.
The purpose of the study is to analyze the correlation between the two non-invasive methods for measuring CO2: PTCO2 and ETCO2, in a group of home-ventilated patients with neuromuscular disease.
The patients will be recruited during a routine follow-up hospitalization for their home-ventilation, and the ETCO2 will be measured during one night, in addition to the routinely measured PTCO2.
1,650 studies on the registry are indexed under Respiratory Insufficiency; 296 are open to participants now.
This study's enrollment of 28 is below the median of 100 across 545 observational studies indexed under Respiratory Insufficiency.
Browse Respiratory Insufficiency studies →Centre d'Investigation Clinique et Technologique 805 is the lead sponsor of 74 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The patients will be recruited among the neuromuscular patients treated at the University Hospital Raymond Pointcaré, Garches (France), during a routine follow-up hospitalization for their home-ventilation.
Exclusion Criteria:
All neuromuscular patients
Device: Monitoring of ETCO2 and PTCO2
Concomitant monitoring of ETCO2 and PTCO2
Also known as: PTCO2: Sentec Capno-Oxymetry (Sentec), ETCO2: Module of the BREAS Vivo 50 home ventilator
concordance between the nocturnal average values of ETCO2 and PTCO2
concordance between the nocturnal average values of the CO2 measured by the two non-invasive techniques ETCO2 and PTCO2
Time frame: one night
concordance between the nocturnal maximal values of ETCO2 and PTCO2
concordance between the nocturnal maximal values of the CO2 measured by the two non-invasive techniques ETCO2 and PTCO2
Time frame: one night
concordance between the variation of the values of ETCO2 and PTCO2
concordance between the variation of the values of the CO2 measured by the two non-invasive techniques ETCO2 and PTCO2
Time frame: one night
concordance between the values of ETCO2, PTCO2 and arterial CO2 (PaCO2) measured at the same time
concordance between the values of ETCO2, PTCO2 and arterial CO2 (PaCO2) measured at the same time
Time frame: one night
influence of circuit leakage on the gradient between PaCO2 and ETCO2
evaluate the influence of circuit leakage on the gradient between PaCO2 and ETCO2
Time frame: one night
This study is completed, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre d'Investigation Clinique et Technologique 805